Valeo Financial Advisors, LLC Stoke Therapeutics, Inc. Transaction History

Valeo Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$30.53 - $41.09 $2,869 - $3,862	-94 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$36.08 - $69.81 $1,298 - $2,513	-36 Reduced 27.69%	94 $4,000
Q3 2020 Oct 28, 2020	SELL	$22.23 - $37.48 $6,846 - $11,543	-308 Reduced 70.32%	130 $4,000
Q1 2020 Apr 13, 2020	BUY	$16.8 - $34.15 $5,107 - $10,381	304 Added 226.87%	438 $9,000
Q3 2019 Oct 15, 2019	BUY	$20.53 - $37.72 $2,751 - $5,054	134 New	134 $3,000

124

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $445M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.